ASHLEY PARICH: Open Payments
NPI 1295921914 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 34 payments from 10 companies in 2025. Trend: 2023 $851 · 2024 $469 · 2025 $898
Food & beverage: $723Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $237 |
| Amgen Inc. | 2 | $182 |
| Sumitomo Pharma America, Inc. | 7 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $95 |
| Sage Therapeutics, LLC | 4 | $92 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Radius Health, Inc. | 1 | $31 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $31 |
| PFIZER INC. | 2 | $31 |
| Organon LLC | 1 | $19 |
Products named: Veozah, PROLIA, MYFEMBREE, ZURZUVAE, Mirena, Qelbree, Tymlos, ABRYSVO.
Industry payments across LA — which companies pay providers there.
